By Blake Brittain WASHINGTON (Reuters) - The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder drug Hetlioz that were previously declared invalid in a dispute with generic drugmake...
Related Keywords
Delaware ,United States ,Washington ,Blake Brittain ,Vanda Hetlioz ,Colm Connolly ,Supreme Court ,Vanda Pharmaceuticals ,Us Supreme Court On ,Drug Administration ,Reuters ,Us Court ,Judge Colm Connolly ,Federal Circuit ,Canada Based Apotex ,Will Dunham ,
comparemela.com © 2020. All Rights Reserved.